Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Satellos Bioscience Inc (MSCL.TO)

Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 96,374
  • Shares Outstanding, K 113,381
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,889 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.36
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.05 on 08/12/24
  • Next Earnings Date 11/27/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.57 +49.12%
on 10/09/24
0.90 -5.56%
on 10/29/24
+0.29 (+51.79%)
since 10/07/24
3-Month
0.45 +88.89%
on 09/30/24
0.90 -5.56%
on 10/29/24
+0.38 (+80.85%)
since 08/07/24
52-Week
0.29 +193.10%
on 11/14/23
0.90 -5.56%
on 10/29/24
+0.50 (+142.86%)
since 11/07/23

Most Recent Stories

More News
Stocks in play: Satellos Bioscience Inc.

Announced a presentation of data at the 29th Annual Congress of the World Muscle Society taking place ...

MSCL.TO : 0.85 (unch)
Stocks in play: Satellos

For the three months ended June 30, 2024, reported a net loss of $6.0 million ($0.05 loss per share), ...

MSCL.TO : 0.85 (unch)
Satellos Bioscience: Q2 Earnings Snapshot

Satellos Bioscience: Q2 Earnings Snapshot

MSCL.TO : 0.85 (unch)
Stocks in play: Satellos Bioscience Inc.

Today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical ...

MSCL.TO : 0.85 (unch)
Stocks in play: Satellos Bioscience Inc.

Announced today the formation of a Clinical Advisory Board comprised of distinguished clinical research ...

MSCL.TO : 0.85 (unch)
Satellos Bioscience Inc. Opens the Market

/CNW/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani...

MSCL.TO : 0.85 (unch)
Stocks in play: Satellos Bioscience Inc.

Announced today its financial results and operational highlights for the year ended December 31, 2023. ...

MSCL.TO : 0.85 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne...

See More

Key Turning Points

3rd Resistance Point 0.90
2nd Resistance Point 0.89
1st Resistance Point 0.87
Last Price 0.85
1st Support Level 0.84
2nd Support Level 0.83
3rd Support Level 0.81

See More

52-Week High 0.90
Last Price 0.85
Fibonacci 61.8% 0.67
Fibonacci 50% 0.59
Fibonacci 38.2% 0.52
52-Week Low 0.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar